Evaluation and Management of Nystagmus with Vertigo in a Patient with Migraine History and Blurred Vision
This patient most likely has vestibular migraine, and you should first perform bedside vestibular testing (including positional maneuvers with fixation blocked) to characterize the nystagmus pattern, then obtain MRI brain without and with contrast to exclude central causes, particularly posterior circulation stroke, before initiating migraine-specific preventive therapy.
Initial Clinical Assessment
The combination of nystagmus, vertigo, migraine history, and visual symptoms creates a diagnostic challenge requiring systematic exclusion of dangerous central causes while recognizing vestibular migraine as the most probable diagnosis.
Key Diagnostic Considerations
Vestibular migraine affects 1-3% of the general population and is characterized by recurrent vestibular symptoms (lasting 5 minutes to 72 hours) with concurrent migraine features 1, 2, 3. Critically, vertigo episodes can occur without concurrent headache, leading to frequent misdiagnosis 3. The delay between migraine onset and vestibular symptoms may span years 3.
However, posterior circulation stroke must be excluded first, as 25-75% of patients with acute vestibular syndrome have cerebrovascular disease, and focal neurologic deficits are absent in one-third to two-thirds of these cases 4.
Immediate Bedside Evaluation
Nystagmus Characterization
Perform positional testing with fixation blocked (using Frenzel goggles or video-oculography):
- In vestibular migraine, positional nystagmus is present in 100% of symptomatic patients when fixation is blocked 5
- The nystagmus is typically low-velocity, sustained, and can be horizontal, vertical, or torsional 5
- Non-paroxysmal positional nystagmus occurs in 92% of vestibular migraine patients during dizzy spells 6
- Spontaneous nystagmus (19%) or headshaking-provoked nystagmus (35%) may also be present 5
Critical Red Flags for Central Pathology
Look for HINTS examination findings suggesting stroke rather than peripheral vestibular disease:
- Normal horizontal head impulse test (suggests central cause)
- Direction-changing nystagmus in primary gaze
- Skew deviation on alternate cover test
If HINTS suggests central pathology or any focal neurologic deficits exist, proceed immediately to neuroimaging 4.
Neuroimaging Strategy
MRI Brain Without and With IV Contrast - REQUIRED
This is the mandatory imaging study for this presentation 4:
- 11% of patients with acute persistent vertigo and no focal neurologic signs have acute infarct on MRI 4
- MRI provides superior soft tissue resolution for detecting posterior fossa lesions, demyelinating disease, and masses
- Gadolinium contrast improves detection of inflammatory, infectious, or demyelinating processes that can mimic vestibular migraine 4
- Brain MRI is unremarkable in 72% of vestibular migraine cases, supporting the diagnosis when negative 6
Additional Imaging Considerations
Include internal auditory canal sequences to exclude vestibular schwannoma or other structural lesions affecting the eighth cranial nerve.
CT imaging is inadequate - detection rate of contributory CNS pathology is <1% in patients with normal neurologic examination 4.
Vestibular Function Testing
Once central causes are excluded:
- Caloric testing or rotary chair testing during symptom-free intervals should be normal in vestibular migraine 5
- Video head impulse testing (vHIT) may show abnormal gain or corrective saccades, though saccades are more common 7
- These tests help differentiate from Menière's disease (unilateral weakness) or vestibular neuritis
Diagnostic Confirmation
Vestibular migraine diagnosis requires 1, 2:
- At least 5 episodes of vestibular symptoms (5 minutes to 72 hours duration)
- Current or previous migraine diagnosis (with or without aura)
- Migraine features (headache, photophobia, phonophobia, or visual aura) in at least 50% of vertigo episodes
- Exclusion of other vestibular disorders
The blurred vision in this patient likely represents visual aura, which supports the vestibular migraine diagnosis when occurring with vertigo episodes.
Management Algorithm
Acute Attack Treatment
For acute vestibular migraine episodes:
- Analgesics and NSAIDs for mild-moderate symptoms
- Do NOT use triptans for isolated vertigo/dizziness episodes 1
- Triptans are appropriate only when headache is prominent
- Antiemetics for nausea/vomiting
Preventive Therapy - PRIMARY TREATMENT GOAL
Initiate preventive medication if attacks are frequent or disabling 8:
First-line options:
- Topiramate - preferred first choice due to lower cost and proven efficacy 8
- Beta-blockers (propranolol) - widely used though evidence specific to vestibular migraine is limited 9
- Amitriptyline - particularly beneficial if depression or sleep disturbances coexist 8
Second-line options (after 2-3 failed preventives):
- CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) 8
- OnabotulinumtoxinA (for chronic migraine) 8
Adjunctive Interventions
- Vestibular rehabilitation therapy may benefit selected patients 2
- Lifestyle modifications: identify and avoid migraine triggers
- Address comorbidities (anxiety, depression, sleep disorders, obesity) as these influence outcomes 8
Common Pitfalls to Avoid
- Assuming peripheral vestibular disease without imaging - stroke risk is too high in this population
- Delaying imaging because neurologic exam is normal - focal deficits are absent in most posterior circulation strokes presenting with vertigo
- Using CT instead of MRI - CT misses most posterior fossa pathology
- Prescribing triptans for isolated vertigo - ineffective and potentially harmful
- Failing to recognize vestibular migraine because headache is absent during vertigo - this occurs frequently
Specialist Referral
Refer to neurology or neuro-otology if:
- Diagnosis remains uncertain after imaging and vestibular testing
- Symptoms progress to chronic pattern (>15 days/month)
- Multiple preventive medications fail
- Atypical features suggest alternative diagnosis
The key to managing this patient is systematic exclusion of dangerous central pathology through appropriate imaging, followed by recognition that vestibular migraine is a distinct clinical entity requiring migraine-specific preventive therapy rather than vestibular suppressants 1, 2, 3.